Sickle Cell Partnership creates demonstration project to treat children in Angola
The Angola Sickle Cell Initiative is teaming up with Bristol-Myers Squibb to provide children with sickle cell disease in Angola with an effective medication where many patients have lacked access. The program will provide thousands of Angolan children regular access to Droxia (hydroxyurea). June 24, 2016